Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1988 Nov;32(11):1720–1724. doi: 10.1128/aac.32.11.1720

Antiherpesvirus activity and mechanism of action of indolo-(2,3-b)quinoxaline and analogs.

J Harmenberg 1, B Wahren 1, J Bergman 1, S Akerfeldt 1, L Lundblad 1
PMCID: PMC175957  PMID: 2855298

Abstract

The antiherpesvirus activity of 14 derivatives of indoloquinoxaline was tested. The most active was 2,3-dimethyl(dimethylaminoethyl)5H-indolo-(2,3-b)quinoxaline, also called B-220. The antiherpesvirus mechanism of B-220 was sought. The compound inhibited replication of herpes simplex virus type 1, cytomegalovirus, and varicella-zoster virus in tissue culture at concentrations of 1 to 5 microM, depending on the cell type used for assay and the amount of virus. Cellular toxicity was seen at a concentration of 10 to 30 microM, and antiviral activity in the human bladder cancer and human embryonic lung fibroblast cell lines tested was found at concentrations 3 to 15 times lower than the concentrations causing cellular toxicity. Viral DNA synthesis, as well as production of early and late viral proteins, was inhibited at 0.5 to 4.5 microM B-220, but viral DNA polymerases tested in vitro were not inhibited at these concentrations. There was no interaction with the pyrophosphate analog foscarnet, and no reversal of the antiviral activity of B-220 occurred with naturally occurring nucleosides. We conclude that the antiviral effect depends on the multiplicity of infection and may occur at the level of viral DNA synthesis and that no interference occurs with pyrophosphate analogs or nucleosides. The more potent activity against viral DNA than against cellular DNA may be caused by a true selectivity for herpesvirus DNA or by the higher metabolism of viral DNA in infected cells.

Full text

PDF
1720

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abele G., Karlström A., Harmenberg J., Shigeta S., Larsson A., Lindborg B., Wahren B. Inhibiting effect of (RS)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine on varicella-zoster virus replication in cell culture. Antimicrob Agents Chemother. 1987 Jan;31(1):76–80. doi: 10.1128/aac.31.1.76. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bastow K. F., Derse D. D., Cheng Y. C. Susceptibility of phosphonoformic acid-resistant herpes simplex virus variants to arabinosylnucleosides and aphidicolin. Antimicrob Agents Chemother. 1983 Jun;23(6):914–917. doi: 10.1128/aac.23.6.914. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Elion G. B., Furman P. A., Fyfe J. A., de Miranda P., Beauchamp L., Schaeffer H. J. Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine. Proc Natl Acad Sci U S A. 1977 Dec;74(12):5716–5720. doi: 10.1073/pnas.74.12.5716. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Eriksson B., Oberg B., Wahren B. Pyrophosphate analogues as inhibitors of DNA polymerases of cytomegalovirus, herpes simplex virus and cellular origin. Biochim Biophys Acta. 1982 Feb 26;696(2):115–123. doi: 10.1016/0167-4781(82)90018-5. [DOI] [PubMed] [Google Scholar]
  5. Gadler H. Nucleic acid hybridization for measurement of effects of antiviral compounds on human cytomegalovirus DNA replication. Antimicrob Agents Chemother. 1983 Sep;24(3):370–374. doi: 10.1128/aac.24.3.370. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Gwaltney J. M., Jr Rhinovirus inhibition by 3-substituted triazinoindoles. Proc Soc Exp Biol Med. 1970 Apr;133(4):1148–1154. doi: 10.3181/00379727-133-34642. [DOI] [PubMed] [Google Scholar]
  7. Harmenberg J. Interactions between virus and antiviral compounds in the host cell. Med Biol. 1984;62(6):299–303. [PubMed] [Google Scholar]
  8. Harmenberg J., Wahren B., Oberg B. Influence of cells and virus multiplicity on the inhibition of herpesviruses with acycloguanosine. Intervirology. 1980;14(5-6):239–244. doi: 10.1159/000149192. [DOI] [PubMed] [Google Scholar]
  9. Harmenberg J., Wahren B., Sundqvist V. A., Levén B. Multiplicity dependence and sensitivity of herpes simplex virus isolates to antiviral compounds. J Antimicrob Chemother. 1985 May;15(5):567–573. doi: 10.1093/jac/15.5.567. [DOI] [PubMed] [Google Scholar]
  10. Huang E. S. Human cytomegalovirus. III. Virus-induced DNA polymerase. J Virol. 1975 Aug;16(2):298–310. doi: 10.1128/jvi.16.2.298-310.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Powell K. L., Purifoy D. J. Nonstructural proteins of herpes simplex virus. I. Purification of the induced DNA polymerase. J Virol. 1977 Nov;24(2):618–626. doi: 10.1128/jvi.24.2.618-626.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Sundqvist V. A., Wahren B. An interchangeable ELISA for cytomegalovirus antigen and antibody. J Virol Methods. 1981 Apr;2(5):301–312. doi: 10.1016/0166-0934(81)90029-x. [DOI] [PubMed] [Google Scholar]
  13. Wahren B., Harmenberg J., Sundqvist V. A., Levén B., Sköldenberg B. A novel method for determining the sensitivity of herpes simplex virus to antiviral compounds. J Virol Methods. 1983 Mar;6(3):141–149. doi: 10.1016/0166-0934(83)90026-5. [DOI] [PubMed] [Google Scholar]
  14. Wahren B., Larsson A., Rudén U., Sundqvist A., Sølver E. Acyclic guanosine analogs as inhibitors of human cytomegalovirus. Antimicrob Agents Chemother. 1987 Feb;31(2):317–320. doi: 10.1128/aac.31.2.317. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Wahren B., Oberg B. Inhibition of cytomegalovirus late antigens by phosphonoformate. Intervirology. 1980;12(6):335–339. doi: 10.1159/000149093. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES